Plozalizumab
Plozalizumab (MLN-1202) is a humanized, selective, and potent anti-CCR2 antibody with antitumor activity, used in the study of malignant melanoma.
Product Specifications
CAS Number
1610761-46-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
CCR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7021426-01 0.02 mg
Recombinant Oncorhynchus masou ATP synthase subunit a (mt-atp6)
Sign In for Pricing
View Details MBS7021426-02 0.1 mg
Recombinant Oncorhynchus masou ATP synthase subunit a (mt-atp6)
Sign In for Pricing
View Details MBS7021426-03 5x 0.1 mg
Recombinant Oncorhynchus masou ATP synthase subunit a (mt-atp6)
Sign In for Pricing
View Details